Home > Products > Novel inhibitors
Cat. No. Product name CAS No.
DCC3799 Nsc750212

Novel inhibitor of lipid metabolism, disrupting tubulin polymerization,suppressing monoglycerol metabolism depleting lipids and inhibiting the growth of both lymphoma and RCC both in vitro and in vivo

DCC3800 Nsc-77053

The first reported BoNT/E small molecule inhibitor

77308-57-7
DCC3801 Nsc-79887

Novel inhibitor of nucleoside hydrolase (NH)

19056-78-1
DCC3802 Nsc-80141

Selective inhibitor of HsEg5

97027-56-0
DCC3803 Nsc-84096

Potent inhibitor of endopeptidase activity of botulinum neurotoxin type A light chain (rBoNT/A-LC)

908813-78-5
DCC3804 Nsc-8891

Tyrosyl-DNA phosphodiesterase (Tdp1) inhibitor

21170-34-3
DCC3805 Nsc-9037

First-in-class probe of Rad6 function, inhibiting Rad6 function and Rad6-Rad18 interaction in the PCNA ubiquitination cascade

3569-82-2
DCC3806 nsc-96626

Novel B-Raf(V600E) inhibitor

27430-18-8
DCC3807 Nsi-189 Phosphate

Novel stimulator of neurogenesis of human hippocampus-derived neural stem cells in vitro and in vivo.

1270138-41-4
DCC3808 Nsmase2-in-1

Novel inhibitor of neutral sphingomyelinase 2 (nSMase2) for the treatment of neurodegenerative diseases

DCC3809 Nsp-116

Novel free radical scavenger, against light-induced photoreceptor cell damage

DCC3810 Nti-007

Potent anti-HBV agent, targeting the NTCP-APOA1-HBx-Beclin1-mediated autophagic pathway

DCC3811 Ntrc-739

Novel nonpeptide selective ligand for NTS2

DCC3812 Ntrc-808

Novel nonpeptide potent and selective partial agonist of the Neurotensin receptor type 2 (NTS2)

DCC3813 Ntrd22

Novel Allosteric Modulator of RNA Binding Targeting the N-Terminal Domain of TDP-43

DCC3814 Ntr-responsive Protac 17-1

The first NTR-responsive PROTAC, incorporating the caging group on the Von Hippel-Lindau (VHL) E3 ubiquitin ligase ligand, efficiently degrading the EGFR protein and subsequently exert antitumor efficacy

DCC3815 Ntz-15

Novel potent STAT3 inhibitor, exhibiting much improved in vivo pharmacokinetic parameters in rats and efficacies against proliferations in multiple cancer cell lines

DCC3816 Ntz-24

Novel potent STAT3 inhibitor

69819-42-7
DCC3817 Ntzdpa

Novel potent and selective non-thiazolidinedione partial Peroxisome_proliferator-activated_receptor>PPARγ agonist, acting as an antibiotic effectively against bacterial persisters

118414-59-8
DCC3818 Nu6155

Novel potent CDK2 inhibitor

DCC3819 Nuc013

Novel DNA methytransferase inhibitor, be significantly safer and more effective than decitabine in xenograft models of human leukemia and colon cancer

DCC3820 Nucc-201177

Novel highly potent and selective MEK4 inhibitor

Page 1395 / Total 1558 FirstPrevNextLastGoto